Literature DB >> 19620307

Different vaccine vectors delivering the same antigen elicit CD8+ T cell responses with distinct clonotype and epitope specificity.

Mitsuo Honda1, Rui Wang, Wing-Pui Kong, Masaru Kanekiyo, Wataru Akahata, Ling Xu, Kazuhiro Matsuo, Kannan Natarajan, Howard Robinson, Tedi E Asher, David A Price, Daniel C Douek, David H Margulies, Gary J Nabel.   

Abstract

Prime-boost immunization with gene-based vectors has been developed to generate more effective vaccines for AIDS, malaria, and tuberculosis. Although these vectors elicit potent T cell responses, the mechanisms by which they stimulate immunity are not well understood. In this study, we show that immunization by a single gene product, HIV-1 envelope, with alternative vector combinations elicits CD8(+) cells with different fine specificities and kinetics of mobilization. Vaccine-induced CD8(+) T cells recognized overlapping third V region loop peptides. Unexpectedly, two anchor variants bound H-2D(d) better than the native sequences, and clones with distinct specificities were elicited by alternative vectors. X-ray crystallography revealed major differences in solvent exposure of MHC-bound peptide epitopes, suggesting that processed HIV-1 envelope gave rise to MHC-I/peptide conformations recognized by distinct CD8(+) T cell populations. These findings suggest that different gene-based vectors generate peptides with alternative conformations within MHC-I that elicit distinct T cell responses after vaccination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620307      PMCID: PMC2858449          DOI: 10.4049/jimmunol.0900581

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

Review 1.  Epitope dominance, competition and T cell affinity maturation.

Authors:  Ross M Kedl; John W Kappler; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2003-02       Impact factor: 7.486

2.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

Review 3.  Private specificities of heterologous immunity.

Authors:  Raymond M Welsh
Journal:  Curr Opin Immunol       Date:  2006-04-04       Impact factor: 7.486

4.  Broad HIV-1 neutralization mediated by CD4-binding site antibodies.

Authors:  Yuxing Li; Stephen A Migueles; Brent Welcher; Krisha Svehla; Adhuna Phogat; Mark K Louder; Xueling Wu; George M Shaw; Mark Connors; Richard T Wyatt; John R Mascola
Journal:  Nat Med       Date:  2007-08-26       Impact factor: 53.440

Review 5.  The biochemistry and cell biology of antigen processing and presentation.

Authors:  R N Germain; D H Margulies
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

6.  An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.

Authors:  C Bergmann; S A Stohlmann; M McMillan
Journal:  Eur J Immunol       Date:  1993-11       Impact factor: 5.532

7.  Cutting edge: major CD8 T cell response to live bacillus Calmette-Guérin is mediated by CD1 molecules.

Authors:  Tetsuo Kawashima; Yoshihiko Norose; Yoshiyuki Watanabe; Yutaka Enomoto; Hidehiko Narazaki; Eiji Watari; Shigeo Tanaka; Hidemi Takahashi; Ikuya Yano; Michael B Brenner; Masahiko Sugita
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

8.  Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120.

Authors:  H Li; K Natarajan; E L Malchiodi; D H Margulies; R A Mariuzza
Journal:  J Mol Biol       Date:  1998       Impact factor: 5.469

9.  Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.

Authors:  Carlota Dobaño; William O Rogers; Kalpana Gowda; Denise L Doolan
Journal:  Immunol Lett       Date:  2007-06-18       Impact factor: 3.685

10.  Macaques vaccinated with live-attenuated SIV control replication of heterologous virus.

Authors:  Matthew R Reynolds; Andrea M Weiler; Kim L Weisgrau; Shari M Piaskowski; Jessica R Furlott; Jason T Weinfurter; Masahiko Kaizu; Taeko Soma; Enrique J León; Caitlin MacNair; Dan P Leaman; Michael B Zwick; Emma Gostick; Solomon K Musani; David A Price; Thomas C Friedrich; Eva G Rakasz; Nancy A Wilson; Adrian B McDermott; Rosanne Boyle; David B Allison; Dennis R Burton; Wayne C Koff; David I Watkins
Journal:  J Exp Med       Date:  2008-10-06       Impact factor: 14.307

View more
  13 in total

Review 1.  Regulation of CD4 T-cell receptor diversity by vaccine adjuvants.

Authors:  Christina K Baumgartner; Laurent P Malherbe
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

2.  MHC-restricted Ag85B-specific CD8+ T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice.

Authors:  Shihoko Komine-Aizawa; Jiansheng Jiang; Satoru Mizuno; Satoshi Hayakawa; Kazuhiro Matsuo; Lisa F Boyd; David H Margulies; Mitsuo Honda
Journal:  Eur J Immunol       Date:  2019-06-19       Impact factor: 5.532

3.  Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates.

Authors:  Lukas Flatz; Cheng Cheng; Lingshu Wang; Kathryn E Foulds; Sung-Youl Ko; Wing-Pui Kong; Rahul Roychoudhuri; Wei Shi; Saran Bao; John-Paul Todd; Mohammed Asmal; Ling Shen; Mitzi Donaldson; Stephen D Schmidt; Jason G D Gall; Daniel D Pinschewer; Norman L Letvin; Srinivas Rao; John R Mascola; Mario Roederer; Gary J Nabel
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

4.  Single-cell gene-expression profiling reveals qualitatively distinct CD8 T cells elicited by different gene-based vaccines.

Authors:  Lukas Flatz; Rahul Roychoudhuri; Mitsuo Honda; Abdelali Filali-Mouhim; Jean-Philippe Goulet; Nadia Kettaf; Min Lin; Mario Roederer; Elias K Haddad; Rafick P Sékaly; Gary J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

5.  Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiation.

Authors:  Rahul Roychoudhuri; Francois Lefebvre; Mitsuo Honda; Li Pan; Yun Ji; Christopher A Klebanoff; Carmen N Nichols; Slim Fourati; Ahmed N Hegazy; Jean-Philippe Goulet; Luca Gattinoni; Gary J Nabel; Michel Gilliet; Mark Cameron; Nicholas P Restifo; Rafick P Sékaly; Lukas Flatz
Journal:  Vaccine       Date:  2014-11-01       Impact factor: 3.641

6.  Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.

Authors:  Marina A Durward; Jerome Harms; Diogo M Magnani; Linda Eskra; Gary A Splitter
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

7.  Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.

Authors:  Blake F Frey; Jiansheng Jiang; Yongjun Sui; Lisa F Boyd; Bin Yu; Gwen Tatsuno; Rolf Billeskov; Shahram Solaymani-Mohammadi; Phillip W Berman; David H Margulies; Jay A Berzofsky
Journal:  J Immunol       Date:  2018-01-26       Impact factor: 5.422

8.  Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.

Authors:  Kylie M Quinn; Andreia Da Costa; Ayako Yamamoto; Dana Berry; Ross W B Lindsay; Patricia A Darrah; Lingshu Wang; Cheng Cheng; Wing-Pui Kong; Jason G D Gall; Alfredo Nicosia; Antonella Folgori; Stefano Colloca; Riccardo Cortese; Emma Gostick; David A Price; Carmen E Gomez; Mariano Esteban; Linda S Wyatt; Bernard Moss; Cecilia Morgan; Mario Roederer; Robert T Bailer; Gary J Nabel; Richard A Koup; Robert A Seder
Journal:  J Immunol       Date:  2013-02-06       Impact factor: 5.422

9.  Clonotypic composition of the CD4+ T cell response to a vectored retroviral antigen is determined by its speed.

Authors:  Georgina Thorborn; Mickaël J Ploquin; Urszula Eksmond; Rebecca Pike; Wibke Bayer; Ulf Dittmer; Kim J Hasenkrug; Marion Pepper; George Kassiotis
Journal:  J Immunol       Date:  2014-07-07       Impact factor: 5.422

10.  Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens.

Authors:  Silvia Ratto-Kim; Jeffrey R Currier; Josephine H Cox; Jean-Louis Excler; Anais Valencia-Micolta; Doris Thelian; Vicky Lo; Eddy Sayeed; Victoria R Polonis; Patricia L Earl; Bernard Moss; Merlin L Robb; Nelson L Michael; Jerome H Kim; Mary A Marovich
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.